Cargando…
Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion
We investigated the efficacy of intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents in branch retinal vein occlusion (BRVO). Databases, including PubMed, EMBASE, and the Cochrane Library, were searched on November 11, 2022. Studies comparing the pro-re-nata (PRN) regimen...
Autores principales: | Chung, Yoo-Ri, Woo, Tae Kyoung, Park, Ha Ryung, Lee, Kihwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372086/ https://www.ncbi.nlm.nih.gov/pubmed/37495760 http://dx.doi.org/10.1038/s41598-023-39303-2 |
Ejemplares similares
-
Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
por: Ito, Yuka, et al.
Publicado: (2015) -
Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion
por: Wang, Jing, et al.
Publicado: (2020) -
Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013) -
Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections
por: Chen, X., et al.
Publicado: (2020) -
Intravitreal injection of conbercept combined with retinal photocoagulation on macular edema secondary to branch retinal vein occlusion
por: Wang, Bing, et al.
Publicado: (2020)